Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Villin-1 is a calcium-regulated actin-binding protein encoded by the VIL1 gene in humans[1][3][4][6]. It is a dominant component of the brush border cytoskeleton, especially in epithelial cells of the gastrointestinal tract and other organs with microvilli[1][3][4][6]. Villin-1 is specialized in modulating actin dynamics through capping, severing, nucleating, and bundling actin filaments, impacting the structure and morphogenesis of microvilli[2][4]. Its function is essential for maintaining intestinal epithelial cell integrity, supporting cell migration, wound repair, and regulating apoptosis, notably protecting against gastrointestinal injury[3][5]. Its highly regulated expression and location make it a sensitive marker for epithelial cells and diseases affecting the intestine[3][5][6]. Villin-1 is not considered a classical drug target (such as a receptor or enzyme), and no drugs are known to modulate it directly, but its dysregulation is linked to various gastrointestinal disorders[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Villin-1 (VIL1).